EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series

Yoshifumi Ubara, Tatsuya Suwabe, Naoki Sawa

Clinical and Experimental Nephrology · 2025

DOI: 10.1007/s10157-024-02597-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Nephrology, 2025. Verfasst von Yoshifumi Ubara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, 2-2-2, Toranomon, Minato, Tokyo, Japan. ubara@toranomon.gr…. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Cysts, Liver Diseases, Polycystic Kidney, Autosomal Dominant. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have achieved good results of renal transarterial embolization (TAE) therapy as an alternative to surgical nephrectomy to decrease renal size in autosomal polycystic kidney disease (ADPKD) patients with enlarged kidneys, but only in patients on dialysis. Renal transplantation is another treatment option, and patients who receive a donor kidney have achieved a reduction in kidney size after surgery. TAE has also been used in polycystic liver disease (PCLD), an extrarenal lesion of ADPKD. Although TAE is effective in some PCLD patients, others develop hepatomegaly, which leads to liver cyst infection and liver failure. Recently, liver transplantation has started to be performed in such patients. Initially, living donor liver transplants were performed from family members, but in 2010, deceased donor liver transplantation became available. This article gives an overview of the history of TAE for ADPKD and PCLD on the basis of our experience.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embolization, TherapeuticCystsLiver DiseasesPolycystic Kidney, Autosomal DominantPolycystic Kidney DiseasesHumansLiver TransplantationTreatment OutcomeMale

Stichwörter der Autor:innen

Autosomal dominant polycystic kidney disease (ADPKD)Polycystic kidney diseasePolycystic liver diseaseTranscatheter arterial embolization therapy (TAE)

Autor:innen und Institutionen

  • Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, 2-2-2, Toranomon, Minato, Tokyo, Japan. ubara@toranomon.gr.jp.
  • Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, 2-2-2, Toranomon, Minato, Tokyo, Japan.

Zitieren

APA

Ubara, Y., Suwabe, T., & Sawa, N. (2025). Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02597-1

Vancouver

Ubara Y, Suwabe T, Sawa N. Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series. Clinical and Experimental Nephrology. 2025. doi:10.1007/s10157-024-02597-1

BibTeX
@article{Ubara2025,
  author = {Ubara, Yoshifumi and Suwabe, Tatsuya and Sawa, Naoki},
  title = {Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series},
  journal = {Clinical and Experimental Nephrology},
  year = {2025},
  doi = {10.1007/s10157-024-02597-1}
}
Kostenlos starten →